About the Authors
- Xin Chen, Michael McClelland, Farah Rahmatpanah, Anne Sawyers, Zhenyu Jia, Dan Mercola
- Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
- Shizhong Xu
- Department of Genetics and Geneticist Botany and Plant Sciences, University of California Riverside, Riverside, California, United States of America
- Michael McClelland
- Vaccine Research Institute of San Diego, San Diego, California, United States of America
D. Mercola and M. McClelland are board members of Proveri Inc. which has a license from the Regents of the University of California for the development of clinical assays for prostate cancer. The other authors declare they have no conflict of interest with this publication. This does not alter the authors’ adherence to all of PLOS ONE’s policies on sharing data and materials.
Conceived and designed the experiments: XC ZJ DM. Performed the experiments: XC AS ZJ. Analyzed the data: XC SX ZJ FR. Wrote the paper: XC ZJ MM DM.